ArticleBlood advances2023
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia.
Constantine S Tam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it
ArticleBlood advances2023
Constantine S Tam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.